Methyl2-azabicyclo[2.1.1]hexane-5-carboxylate;hydrochloride, 98%, 500mg

(S)-3-(tert-Butoxycarbonyl)thiazolidine-2-carboxylic acid, 95.0%, 10g

Ethyl (diethoxyphosphoryl)formate, 98%, 500g

2-Chlorobenzotrifluoride>98.0%(GC)25g

2,6-DI-O-METHYL-BETA-CYCLODEXTRIN, 95%, 100g

tert-Butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 1g

monoclonal de souris anti-kératine K20, IT-Ks20.8, 1 ml

(2-Chlorophenoxy)acetic acid, 95.0%, 100g

4-chloro-1-phthalazinol, 95.0%, 10g

2-Piperidinecarboxamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-1-[(4-methylphenyl)sulfonyl]-, (2R)-, 98%, 100mg

trans-1-(tert-Butoxycarbonyl)-4-(3-fluorophenyl)pyrrolidine-3-carboxylic acid, 95.0%, 250mg

Methylpiperazine-1-carboxylate, 98.00%, 1g

METHYL 2-([(4-FLUOROPHENYL)METHYL]AMINO)-1,3-THIAZOLE-4-CARBOXYLATE, 95.0%, 250mg